Quick Answer
Voyager Therapeutics, Inc. reported Net Income of -$119.72 million for fiscal year 2025.
Voyager Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$119.72M | -84.2% |
| 2024 | -$65.00M | -149.1% |
| 2023 | $132.33M | +385.1% |
| 2022 | -$46.41M | +34.8% |
| 2021 | -$71.20M | -293.8% |
| 2020 | $36.74M | +184.3% |
| 2019 | -$43.60M | +50.6% |
| 2018 | -$88.29M | -24.9% |
| 2017 | -$70.70M | -75.9% |
| 2016 | -$40.19M | -35.5% |
| 2015 | -$29.67M | -81.8% |
| 2014 | -$16.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.89M | -208.4% | +16.4% |
| June 30, 2025 | -$33.38M | -229.2% | -7.6% |
| March 31, 2025 | -$31.02M | -173.8% | -243.0% |
| September 30, 2024 | -$9.04M | +65.1% | +10.8% |
| June 30, 2024 | -$10.14M | +54.3% | +10.5% |
| March 31, 2024 | -$11.33M | -109.1% | +56.3% |
| September 30, 2023 | -$25.90M | -247.0% | -16.6% |
| June 30, 2023 | -$22.21M | -16.4% | -117.9% |
- Voyager Therapeutics, Inc. showed a decrease of -84.2% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Voyager Therapeutics, Inc.’s net income has declined by 633.7% (from -$16.32 million to -$119.72 million).
- The most recent figure is from Voyager Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: